Cargando…
Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care
BACKGROUND: Anticancer treatment exposes patients to negative consequences such as increased toxicity and decreased quality of life, and there are clear guidelines recommending limiting use of aggressive anticancer treatments for patients near end of life. The aim of this study is to investigate the...
Autores principales: | Haukland, Ellinor Christin, von Plessen, Christian, Nieder, Carsten, Vonen, Barthold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265218/ https://www.ncbi.nlm.nih.gov/pubmed/32482172 http://dx.doi.org/10.1186/s12904-020-00579-0 |
Ejemplares similares
-
Contribution of adverse events to death of hospitalised patients
por: Haukland, Ellinor Christin, et al.
Publicado: (2019) -
Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2023) -
Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
por: Nieder, Carsten, et al.
Publicado: (2022) -
Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)
por: Dalhaug, Astrid, et al.
Publicado: (2010) -
Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer
por: Nieder, Carsten, et al.
Publicado: (2017)